MissionIR Articles
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Appoints Former GM Exec as Chief Commercial Officer
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the hiring of John Schwegman as its chief commercial officer (“CCO”) for Mullen’s line of commercial vehicles. Prior to joining Mullen, Schwegman spent 35 years of his career at General Motors (“GM”), holding various executive-level roles and leading global teams across four continents.…
-
MissionIRNewsBreaks – Tingo Inc. (TMNA) Enters Trade Agreement with Nigeria Ag/Commodities Umbrella Organization
Tingo (OTC: TMNA), a leading agri-fintech business in Africa, has signed a trade agreement with the All Farmers Association of Nigeria (“AFAN”). Tingo has signed a merger agreement to be acquired by MICT Inc. (NASDAQ: MICT); AFAN is the umbrella body of the 56 recognized commodities and agricultural associations in Nigeria. According to the agreement, AFAN…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Completes Strategic CASE Acquisition
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, has announced the completion of its acquisition of CASE Emergency Systems (“CASE”). The acquisition is designed to contribute to Knightscope’s sales strategy based on CASE’s relationships with numerous key clients, which include but are not limited to: New York Police Department (“NYPD”), New York City…
-
MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Data Supporting SPC-14’s Therapeutic Potential for Alzheimer’s
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced proof-of-concept data supporting the therapeutic potential of SPC-14 as a treatment for Alzheimer’s disease, as demonstrated in a mouse model. According to the announcement, the research was conducted as part of a sponsored agreement with Columbia…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Anticipates Leadership Position in Alternative Cannabinoid Market Segment
Flora Growth Corp. (NASDAQ: FLGC), a global cannabis cultivator, product manufacturer and distributor, is measuring its success in rapidly rising revenues brought on by strategic acquisitions and the expanding international movement of its brands. “The company recently reported a 604% increase YoY in its H1 revenues to about $15 million, which was also a 117%…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Breaks Ground at Core RNG Expansion Project, Provides Construction Update
EverGen (TSX.V: EVGN) (OTCQB: EVGIF) today announced that construction has commenced at the company’s Core RNG Expansion Project at Fraser Valley Biogas. Located in Abbotsford, British Columbia, Fraser Valley Biogas (“FVB”) has been in operation since 2011 and is the original producing renewable natural gas (“RNG”) project in Western Canada to supply FortisBC’s network. The…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Innovative Robot Roadshow Makes Stop in Dallas
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), and its Robot Roadshow are spending the day in Dallas. The roadshow is a free, engaging experiential event that is designed to provide potential clients, media and investors with an opportunity to see Knightscope’s game-changing security robots up close and personal. The stop in…
-
MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Schedules Release of Q3 2022 Results, Conference Call
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has announced that it will provide a business update and release its financial results for the third quarter of 2022 following the close of the market on Tuesday, Nov. 8, 2022. In addition, Cepton will hold a conference call and webcast at…
-
MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Agreement with Columbia University to Extend Research Pact
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, has entered into an agreement with Columbia University to extend its current research partnership efforts. The agreement outlines certain assets that are currently under development regarding the work of associate professor of clinical Neurobiology Dr. Christine Ann Denny…
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Reports Assay Results from Iska Iska Drills
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, has been conducting an ongoing drilling program at its Iska Iska silver-tin polymetallic project and is reporting on two diamond drill holes. According to the announcement, drill hole…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Featured in BioWorld(TM) MedTech Article
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed an innovative platform for heart attack detection anytime, anywhere, was featured in a recent BioWorld(TM) MedTech article. “HeartBeam Inc. has been awarded a patent for what it called ‘the first and only’ 3D-vector, 12-lead ECG platform for heart attack detection, this in conjunction with a…
-
MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Continues Focus to Create the Best Psychedelic Therapies for Patients
Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, is conducting a phase 1/2a trial evaluating CYB003, its lead investigational molecule and the first-ever novel psilocybin analog to enter clinical development. “The in-human trial is critical to the company’s continued development of…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Anticipating 2023 IND Application for Secondary Portfolio Candidate
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical innovator, is currently conducting a potentially pivotal global phase 2 clinical trial in humans to test the effectiveness of its anti-glioblastoma (“GBM”) drug candidate – Berubicin. Testing of Berubicin resulted in a notable success with evidence of improved survival among a dozen safety trial participants recruited by the drug’s…
-
MissionIRNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Partners with LidarSwiss to Create Nano P60 System
Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, announced that LidarSwiss Solutions GmbH is deploying its Sora(TM) lidar technology in the company’s drone-based mapping and analytics solution, which is available for infrastructure management and engineering design applications. The full Nano P60 system is on display at the INTERGEO event, held…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Continues to Broaden Reach with Fr8App B2B Marketplace
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), an over-the-road shipping technology innovator, has developed an AI-powered marketplace solution for optimizing and automating the supply chain process to help keep trucks moving with minimal obstacles. “The company’s Fr8App B2B marketplace is its flagship product in a suite powered by AI and machine learning technology that helps connect shippers…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Marks Milestone Toward Unique and Uncompromising EV Experience
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, recently announced a partnership with Watergen Inc., an Israel-based company building technology and equipment that create drinking water from the air, to develop and equip Mullen’s portfolio of EVs with technology that will produce fresh drinking water for in-vehicle consumer and commercial application. “Watergen’s technology…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Executes on Several Clinical, Operational Advancements in Pursuit of GBM Treatment
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, recently released its financial results for the second quarter of the fiscal year ended June 30, 2022. “CNS kicked off Q3 2022 with approximately $9 million in cash, and…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Pipeline Addressing Severe Unmet Patient Needs
Lexaria Bioscience Corp. (NASDAQ: LEXX), a biotechnology company focusing its attention and resources on pursuing the enhancement of the bioavailability of a diverse and broad range of active pharmaceutical ingredients, developed the patented DehydraTECH(TM) drug delivery technology. “The company has evidenced, through in-vivo, in-vitro and pre-clinical testing, that DehydraTECH delivers more APIs at a faster…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Show Takes the Spotlight in Lebanon, Ohio
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, most recently hosted its Robot Roadshow at Miami Valley Gaming in Lebanon, Ohio, on Oct. 12, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations…
-
MissionIRNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Participate at Upcoming LD Micro Main Event XV Conference
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, is slated to present at this month’s LD Micro Main Event XV Conference. Scheduled for Oct. 25–27, 2022, the three-day event will be held in Los Angeles. HeartBeam CEO and founder Branislav…
Search Articles
Latest Articles
- Beeline Holdings, Inc. (NASDAQ: BLNE) Clears Debt and Boosts Revenue, On Track to Becoming Cash Flow Positive by Early 2026
- MissionIRNewsBreaks – Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) Highlighted in Cantor Report for Growth Potential and Sector Strength
- MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) to Begin Trading as Solmate (NASDAQ: SLMT) on Oct. 3
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Builds Domestic Supply Chain Using RapidSX Technology
- Forward Industries Inc. (NASDAQ: FORD) Is ‘One to Watch’